Hedingen, September 30, 2022 Solenis and Kolb Distribution Ltd. a unit of KLK Kolb Group, have announced that Solenis has entered into a definitive agreement to acquire the latter’s paper …
HPC Today Interview
Dr. Anja Vonderhagen, Executive Director KLK Kolb, was interviewed by HPC Today about sustainable innovation at our company. Hedigen, June 2019.
Tailor-made excipients, developed the Kolb way
Hedingen, December 2018. Kolb’s article on tailor-made excipients has been published on European Pharmaceutical Review. In there, we describe what makes our approach to tailor-made products special. You can read …
Chemanager interview
Kolb Distribution, wholly owned subsidiary of Kuala Lumpur Kepong Berhad (KLK), completed the acquisition of Elementis Specialties Netherlands (ESN), located in Delden, the Netherlands. As of Feb. 28, 2018, ESN …
Official closing of Kolb’s acquisition
Kolb Distribution AG, wholly owned subsidiary of Kuala Lumpur Kepong Berhad (KLK), acquired Elementis Specialties Netherlands (ESN), located in Delden, the Netherlands. As of this day, Elementis Specialties Netherlands is …
Kolb received the certificate of GMP compliance by Swissmedic
Kolb in Hedingen has been authorised by SwissMedic to manufacture and distribute active pharmaceutical ingredients and is subject to regular GMP inspections. Swissmedic is the Swiss Agency for the licensing …